Loading…
Conexeu Sciences Inc. is projected to rise to $16.11 by 2027, a +18% move from its current price of $13.63.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $12.75 | $13.62 | $14.55 | 0.00% |
| May 30 | $12.41 | $13.62 | $14.96 | 0.00% |
| May 31 | $12.15 | $13.62 | $15.27 | -0.01% |
| Jun 1 | $11.94 | $13.62 | $15.55 | -0.01% |
| Jun 2 | $11.75 | $13.62 | $15.79 | -0.01% |
| Jun 3 | $11.59 | $13.62 | $16.01 | -0.01% |
| Jun 4 | $11.44 | $13.62 | $16.22 | -0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.44 | $13.62 | $16.22 | -0.02% |
| Week 2 | $10.64 | $13.62 | $17.43 | -0.03% |
| Week 3 | $10.06 | $13.62 | $18.43 | -0.05% |
| Week 4 | $9.60 | $13.62 | $19.31 | -0.07% |
| Week 5 | $9.21 | $13.61 | $20.11 | -0.08% |
| Week 6 | $8.88 | $13.61 | $20.87 | -0.10% |
| Week 7 | $8.58 | $13.61 | $21.60 | -0.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Conexeu Sciences Inc. (CNXU) is a healthcare company that develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. Its patented collagen-based scaffold products include a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration.
CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company was founded in 2022 and is based in Reno, Nevada.
CNXU is the common stock trading in the healthcare sector. The current price is $14.40, and the stock is ranked 5528.
The 3- to 5-year price outlook shows upside potential, with the average forecast rising from $14.40 in 2026 to $37.95 in 2030 and to $304.18 in 2050.
Max forecast values reach $55.76 in 2030, $215.72 in 2040, and $570.21 in 2050, illustrating substantial upside in the longer term. The forecast sentiment shifts from neutral in 2026 to bullish from 2027 onward and remains bullish through 2050.
A major floor 4.1% below — a decisive break under it would weaken the trend.
The nearest floor, 4.1% below — buyers have tended to step in here.
The nearest ceiling, 5.7% above — a clean break opens room to run.
A major ceiling 5.7% above — clearing it would confirm fresh momentum.
Key CNXU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.07 | $13.63 | $21.19 | 0% | Neutral | |
| $10.38 | $16.11 | $26.99 | +18% | Neutral | |
| $9.97 | $17.12 | $31.13 | +26% | Bullish | |
| $15.61 | $29.37 | $56.81 | +116% | Bullish | |
| $18.41 | $37.79 | $76.91 | +177% | Bullish | |
| $17.83 | $39.62 | $84.21 | +191% | Bullish | |
| $22.86 | $50.80 | $112.18 | +273% | Bullish | |
| $22.06 | $49.03 | $112.02 | +260% | Bullish | |
| $21.42 | $47.60 | $109.49 | +249% | Bullish | |
| $27.20 | $60.45 | $139.03 | +344% | Bullish | |
| $49.54 | $110.08 | $253.18 | +708% | Bullish | |
| $134.21 | $298.24 | $685.95 | +20.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.07 | $13.63 | $16.47 | +0.00% |
| June 2026 | $11.21 | $13.74 | $17.65 | +0.87% |
| July 2026 | $10.81 | $13.60 | $18.11 | -1.08% |
| August 2026 | $11.34 | $14.57 | $19.94 | +7.15% |
| September 2026 | $11.58 | $15.14 | $21.18 | +3.91% |
| October 2026 | $10.80 | $14.34 | $20.46 | -5.29% |
| November 2026 | $10.35 | $13.95 | $20.25 | -2.72% |
| December 2026 | $10.52 | $14.37 | $21.19 | +3.02% |
Click any year to see its month-by-month CNXU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CNXU is projected to trade between $13.07 and $21.19, averaging $13.63 — a potential gain of 0% from today's $13.63. A consolidation phase looks the most probable path here.
Conexeu Sciences Inc.'s 2027 outlook centres on $16.11, within a $10.38 to $26.99 range. That is up +18% on the projected 2026 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2028, CNXU could reach as high as $31.13, with a base case around $17.12 and support toward $9.97 — roughly +26% from $13.63. Buyers look set to stay in control over this stretch.
Expect CNXU to range from $15.61 to $56.81 through 2029. The $29.37 average target implies a +116% move from current prices. That is up +72% on the projected 2028 average. Momentum favours further upside here.
The CNXU price prediction for 2030 points to an average of $37.79 (low $18.41, high $76.91) — a potential gain of +177% on today's $13.63. Buyers look set to stay in control over this stretch.
In 2031, CNXU is projected to trade between $17.83 and $84.21, averaging $39.62 — a potential gain of +191% from today's $13.63. That is up +5% on the projected 2030 average. Momentum favours further upside here.
Conexeu Sciences Inc.'s 2032 outlook centres on $50.80, within a $22.86 to $112.18 range. That is up +28% on the projected 2031 average. That marks a +273% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CNXU could reach as high as $112.02, with a base case around $49.03 and support toward $22.06 — roughly +260% from $13.63. Momentum favours further upside here.
Expect CNXU to range from $21.42 to $109.49 through 2034. The $47.60 average target implies a +249% move from current prices. That is -3% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The CNXU price prediction for 2035 points to an average of $60.45 (low $27.20, high $139.03) — a potential gain of +344% on today's $13.63. Momentum favours further upside here.
In 2040, CNXU is projected to trade between $49.54 and $253.18, averaging $110.08 — a potential gain of +708% from today's $13.63. That is up +82% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Conexeu Sciences Inc.'s 2050 outlook centres on $298.24, within a $134.21 to $685.95 range. That is up +171% on the projected 2040 average. That marks a +20.9x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CNXU today (≈ 73.394495 CNXU) could be worth
$21,889.04
+$20,889.04 (+2089%) by 2050 · US Dollar
Based on the average projected CNXU price of $298.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNXUwould be worth at today's price.
$1,000 invested in CNXU on May 21, 2026 (≈ 76.511096 CNXU) would be worth
$1,042.46
+$42.46 (+4.2%) today · 1.04× · US Dollar
Based on a CNXU entry price of $13.07 vs. today's $13.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.07 | $1,042.46 | +4.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNXU forecast.
Our base-case forecast reaches $27.00 around 2029.
In the near term, the forecast shows a steady ascent in averages: 2026 avg $14.40, 2027 avg $19.17, 2028 avg $22.60, 2029 avg $30.98, and 2030 avg $37.95, with bullish sentiment accompanying the later years.
From 2031 to 2035 the averages continue higher: 2031 $42.89, 2032 $52.05, 2033 $55.66, 2034 $60.36, and 2035 $71.56, all labeled bullish in the data.
Longer-term projections show substantial upside: 2040 avg $126.11 with a max of $215.72 and ROI of 775.8%, and 2050 avg $304.18 with a max of $570.21 and ROI of 2012.3%, both bullish. These are estimates, not guarantees, and outcomes depend on factors including regulatory clearance and market adoption of collagen-based scaffold therapies.
Tap a question to reveal the answer.
Avg $37.95; min $27.88; max $55.76; ROI 163.6%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with averages rising to $37.95 by 2030 and $304.18 by 2050 and ROI up to 2012.3%. These are estimates, not guarantees.
Yes. The max forecast includes 2040 max $215.72 and 2050 max $570.21, indicating potential to exceed $100 in the longer term.
The 30-day range is $14.40; support at $13.07; resistance at $14.40; sentiment is NEUTRAL.
Current price is $14.40 and the stock is ranked 5528.
Conexeu Sciences Inc. Community Discussion
0Share your Conexeu Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.